Is Alpha Teknova, Inc. (TKNO) a Buy, Sell, or Hold?
NASDAQ : TKNO
Alpha Teknova, Inc.
$6.72 USD
$0.26 (4.02%)
- Volume
- 175.51K
- Average Volume
- 154.8K
- Market Capitalization
- $360.29M
- P/E Ratio
- -21.33
- Dividend Yield
- 0.00%
- Price Target
- $7.50
- Year High
- $6.92
- Year Low
- $1.91
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.49
Company Overview
NASDAQ
Stephen Gunstream
Drug Manufacturers - Specialty & Generic
Healthcare
TKNO
158
US
USD
Liquidity Metrics
0.44
4.49
3.48
0.87
0.00
Sales & Valuation
$40.52M
8.24
5.76
-50.37
-0.13
Profitability
-$0.32
-$17.26M
-38.37%
-38.16%
-24.94%
-17.49%
P/E Metrics
-21.33
-0.67
-0.67
Analyst Price Target & Rating
$7.50
$8.00
$7.00
1/5
3 Analysts
-10.40%
Financial Health Scores
4.36
3/9
$23.95M
$95.88M
$33.28M
-$15.8M
Key Metrics (TTM)
$367.75M
8.42
-33.27
4.49
-24.94%
-17.38%
-4.84%
-2.07%
114 days
Company Executives
| Name | Title |
|---|---|
| Damon A. Terrill | General Counsel, Chief Compliance Officer & Secretary |
| Matthew C. Lowell | Chief Financial Officer |
| Stephen Gunstream | President, Chief Executive Officer & Director |
| Jennifer Henry | Senior Vice President of Marketing |
Poll Results
No votes yet today — be the first to share your view!
About Alpha Teknova, Inc. (NASDAQ:TKNO) Stock
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract ... development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade
2026-08-10 10:57:12
The mean of analysts' price targets for Alpha Teknova (TKNO) points to a 35.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Alpha Teknova Q2 Earnings Call Highlights
2026-08-06 02:05:42
Alpha Teknova NASDAQ: TKNO reported second-quarter revenue growth of 18% from a year earlier, surpassing $12 million for its highest quarterly revenue in the company's 30-year history. The company raised its full-year revenue outlook, citing first-half performance and confidence in the second half of 2026.
Alpha Teknova, Inc. (TKNO) Q2 2026 Earnings Call Transcript
2026-08-05 21:00:07
Alpha Teknova, Inc. (TKNO) Q2 2026 Earnings Call Transcript
Teknova Reports Second Quarter 2026 Financial Results
2026-08-05 16:01:00
Second quarter 2026 total revenue was $12.2 million, up 18% over the same quarter prior year Company raises 2026 revenue guidance to $45-47 million Launched proprietary AI-powered Build-Tek™ custom order configurator, giving developers a faster path from preclinical to clinical manufacturing HOLLISTER, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the second quarter ended June 30, 2026.
2026-08-05 08:59:00
HOLLISTER, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched Build-Tek™, an AI-powered custom order configurator that enables developers of therapies and diagnostics to design complex custom products and submit a request for quote in minutes.
2026-08-05 07:59:31
Wall Street analysts reshuffled their ratings on Wednesday, sending some familiar names higher while punishing others with sharp target cuts. Find out which stocks got surprise upgrades and which ones analysts are now walking away from.
Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-22 16:01:00
HOLLISTER, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, following the close of market.
Frequently Asked Questions
-
What is the current Alpha Teknova, Inc. (TKNO) stock price?
-
Alpha Teknova, Inc.(NASDAQ:TKNO) stock price is $6.72 in the last trading session. During the trading session, TKNO stock reached the peak price of $6.92 while $1.91 was the lowest point it dropped to. The percentage change in TKNO stock occurred in the recent session was 4.02% while the dollar amount for the price change in TKNO stock was $0.26.
-
TKNO's industry and sector of operation?
-
The NASDAQ listed TKNO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of TKNO?
-
Damon A. Terrill | General Counsel, Chief Compliance Officer & Secretary
Matthew C. Lowell | Chief Financial Officer
Stephen Gunstream | President, Chief Executive Officer & Director
Jennifer Henry | Senior Vice President of Marketing
| -
How many employees does TKNO have?
-
Number of TKNO employees currently stands at 158. TKNO operates from 2290 Bert Drive, Hollister, CA 95023, US.
-
Link for TKNO official website?
-
Official Website of TKNO is: https://www.teknova.com
-
How do I contact TKNO?
-
TKNO could be contacted at phone #831 637 1100 and can also be accessed through its website. TKNO operates from 2290 Bert Drive, Hollister, CA 95023, US.
-
How many shares of TKNO are traded daily?
-
The average number of TKNO shares traded daily for last 3 months was 154.8K.
-
What is the market cap of TKNO currently?
-
The market value of TKNO currently stands at $360.29M with its latest stock price at $6.72